Why Spero Therapeutics Shares Are Up Over 100% Today

Spero Therapeutics Inc SPRO shares are trading higher by 120% to $1.60 during Tuesday's trading session after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.

What Happened?

During the Type A meeting, the FDA indicated that positive results from an additional Phase 3 trial supported by confirmatory nonclinical efficacy evidence could be sufficient to support the approval of tebipenem HBr for cUTI, including pyelonephritis for a limited use indication...Read More

See Also: Here's Why HyreCar Shares Are Skyrocketing Over 50% Higher Tuesday

According to data from Benzinga Pro, Spero Therapeutics has a 52-week high of $19.87 and a 52-week low of $0.68.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Penny StocksMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!